<DOC>
	<DOCNO>NCT00106860</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness experimental drug , benzodiazepine drug , long-term use effect quality life , social occupational functioning , sleep , daytime sedation subject anxiety disorder .</brief_summary>
	<brief_title>A Long-Term Study Continuing From Study 04-001-01 Experimental Medication Adults With Anxiety Disorder</brief_title>
	<detailed_description>This trial long-term , open label , safety efficacy study experimental medication adult Generalized Anxiety Disorder ( GAD ) . To enroll study , investigator patient must first participate Jazz Pharmaceuticals , Inc. Protocol 04-001-01 . The study design four stage last total 37 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Complete Study 0400101 Able take medication 9 month Understand sign Informed Consent Comply studyrelated procedure Women child bear potential must confirm negative urine pregnancy test Lack clinically significant abnormality health Experienced SAEs ( serious adverse event ) relate possibly relate study drug participation Study 0400101 Early termination study 0400101 Any new condition could interfere evaluation subject , interpretation safety data , compliance protocol requirement Experiencing AEs ( adverse event ) opinion investigator , per protocol , study drug administration safe participation study would preclude . Taken disallow medication note Study 0400101 completion Study 0400101 entry trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>Generalized Anxiety Disorder</keyword>
</DOC>